- Home
- POCI vs GDTC Comparison
POCI vs GDTC Comparison
Compare POCI & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- GDTC
- Stock Information
- Founded
- POCI 1982
- GDTC 2018
- Country
- POCI United States
- GDTC Singapore
- Employees
- POCI N/A
- GDTC N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- POCI Health Care
- GDTC Health Care
- Exchange
- POCI Nasdaq
- GDTC Nasdaq
- Market Cap
- POCI 27.2M
- GDTC 25.1M
- IPO Year
- POCI N/A
- GDTC 2023
- Fundamental
- Price
- POCI $5.23
- GDTC $2.17
- Analyst Decision
- POCI
- GDTC Buy
- Analyst Count
- POCI 0
- GDTC 1
- Target Price
- POCI N/A
- GDTC $5.00
- AVG Volume (30 Days)
- POCI 16.0K
- GDTC 22.4K
- Earning Date
- POCI 11-14-2024
- GDTC 01-01-0001
- Dividend Yield
- POCI N/A
- GDTC N/A
- EPS Growth
- POCI N/A
- GDTC N/A
- EPS
- POCI N/A
- GDTC N/A
- Revenue
- POCI $18,980,148.00
- GDTC $330,254.00
- Revenue This Year
- POCI N/A
- GDTC $14.71
- Revenue Next Year
- POCI N/A
- GDTC N/A
- P/E Ratio
- POCI N/A
- GDTC N/A
- Revenue Growth
- POCI N/A
- GDTC N/A
- 52 Week Low
- POCI $3.47
- GDTC $1.20
- 52 Week High
- POCI $6.90
- GDTC $5.50
- Technical
- Relative Strength Index (RSI)
- POCI 63.01
- GDTC 47.02
- Support Level
- POCI $4.38
- GDTC $2.11
- Resistance Level
- POCI $5.35
- GDTC $2.60
- Average True Range (ATR)
- POCI 0.42
- GDTC 0.33
- MACD
- POCI 0.14
- GDTC -0.07
- Stochastic Oscillator
- POCI 93.62
- GDTC 34.42
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.